Relationships among islet cell antibodies, residual β-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: Use of a sensitive C-peptide radioimmunoassay-Reference-Cited by-同舟云学术

Relationships among islet cell antibodies, residual β-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: Use of a sensitive C-peptide radioimmunoassay

Published:1990-09 Issue:9 Volume:39 Page:925-930
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Nakanishi Koji,Kobayashi Tetsuro,Miyashita Hikari,Ohkubo Minoru,Sugimoto Tadao,Murase Toshio,Kosaka Kinori,Inouye Ken,Kono Masao

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Risk factors for progression of diabetic retinopathy in patients with insulin-dependent diabetes mellitus;Ohkubo;Ann Jpn Soc Res Diabetes Complications,1988

2. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes;Lutterman;Diabetologia,1981

3. Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control;Fukuda;Diabetes,1988

4. Prevalence of residual β-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon;Hendriksen;Diabetologia,1977

5. Beta-cell function and metabolic control in insulin treated diabetics;Madsbad;Acta Endocrinol,1980

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower Insulin-Dose Adjusted A1c (IDAA1c) Is Associated With Less Complications in Individuals With Type 1 Diabetes Treated With Hematopoetic Stem-Cell Transplantation and Conventional Therapy;Frontiers in Endocrinology;2019-11-19

Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-11

3. Type 1 diabetes: A predictable disease;World Journal of Diabetes;2015

4. Residual C-peptide in type 1 diabetes: what do we really know?;Pediatric Diabetes;2014-03

5. Residual -Cell Function 3-6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents;Diabetes Care;2013-08-29